| Literature DB >> 26154665 |
Abstract
Kawasaki disease (KD) must be considered in the differential diagnosis of any child with fever for 4 to 5 days and compatible clinical and laboratory features, and in any infant with prolonged fever and compatible laboratory features, even in the absence of the classic clinical signs. Prompt therapy is required, because delayed or unrecognized KD can lead to lifelong heart disease or death in previously healthy children. Most children with KD respond to a single 2 g/kg dose of intravenous gammaglobulin with oral aspirin, but a small subset require additional therapies to resolve the clinical illness.Entities:
Keywords: Acquired pediatric heart disease; Coronary artery aneurysm; Myocardial infarction; Prolonged fever; Systemic inflammation
Mesh:
Substances:
Year: 2015 PMID: 26154665 PMCID: PMC4552602 DOI: 10.1016/j.idc.2015.05.006
Source DB: PubMed Journal: Infect Dis Clin North Am ISSN: 0891-5520 Impact factor: 5.982